Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
AAPL$353.05+3.49(+1.00%)Green Electronics Manufacturing - Global Strategic Business Report 2026: Capitalize on a 24.6% CAGR and $90.8 Billion by 2032, Led by Apple, BYD, Foxconn, Samsung, and Siemens9:47:48 AM ETDD$152.14+1.36(+0.90%)Global Roofing Market: Size, Share, Trends and Forecast 2026-2032 | Market to Reach $377.73 Billion as Climate Resilience, Energy Upgrades, and AI-Enabled Inspections Drive 5% CAGR9:46:38 AM ETV$438.22+1.63(+0.37%)Visa Releases First-of-Its-Kind Industry Benchmark for AI Shopping; Almost Half of Test Runs Fail9:43:00 AM ETCAT$572.58-18.52(-3.13%)Demolition Tools Market - Global Forecast 2026-2032 | Market to Reach USD 4.81 Billion as Battery Power, AI, and Circular Construction Drive Growth9:36:39 AM ETARM$173.14-19.14(-9.95%)Arm Just Shipped 10 Billion Chips in a Single Quarter for the First Time9:31:16 AM ETAVGO$308.81-16.89(-5.19%)Power Semiconductor Module Market - Global Forecast 2026-2032 | Electrification, AI Data Centers, and Wide-Bandgap Adoption Drive 7.68% CAGR Toward USD 76.66 Billion9:30:42 AM ETMSFT$546.52-9.49(-1.71%)Tech Volatility Grips Stock Market as Blue Chips Lead; OpenAI to Pay for Data Center Power9:30:13 AM ETPLTR$158.12-13.62(-7.93%)Is Palantir Stock a Buy on the Dip as Revenue Continues to Surge?9:30:00 AM ETTMO$697.79-8.24(-1.17%)AI in Genomics Market Size, Share, Growth, and Competitive Analysis - Global Forecast 2026-2035 | 32.40% CAGR to USD 14.55 Billion as Precision Medicine and Drug Discovery Scale9:27:39 AM ETC$124.75-0.02(-0.02%)UPDATE 7-Oil rises as investors weigh uncertainties around Iran war9:25:37 AM ETAMZN$265.38-0.81(-0.30%)Global Delivery Drones Market by Payload, Range, MTOW, Platform, Application, and Region - Forecast to 2031 | Healthcare and Hybrid Drones Fuel 21.6% CAGR to $7.65 Billion9:23:39 AM ETRDW$6.67-1.04(-13.49%)BUZZ-US STOCKS ON THE MOVE-ConocoPhillips, Sezzle, Cardinal Health9:20:53 AM ETAMD$431.66-57.03(-11.67%)Heterogeneous Computing Market Size and Share - Industry Trends and Growth Forecasts (2026-2031) | Generative AI and Cloud Adoption Fuel 21.87% CAGR9:20:42 AM ETCOHR$176.44-18.78(-9.62%)Coherent Now Sees Growth Above 60% and Its First $4 Billion Quarter by Fiscal 20289:19:53 AM ETXOM$172.73+3.33(+1.97%)Liz Ann Sonders Says "Rotation Is the New Momentum Trade." Here’s Where Money Could Move Next9:19:49 AM ETAMD$431.66-57.03(-11.67%)Global Accelerated Computing Market Size, Share, Industry Trends, and Growth Forecasts, 2026-2031 | AI Training and Edge Inference Fuel 20.19% CAGR and Custom Silicon Opportunities9:19:40 AM ETFISI$41.32+0.86(+2.13%)Virtual Desktop Infrastructure (VDI) Endpoint Market Size, Share, Trends, and Forecast 2026-2031 | Hybrid Work and Zero Trust Drive 14.48% CAGR Toward USD 9.89 Billion9:18:45 AM ETMSFT$546.52-9.49(-1.71%)Carbon-Aware Computing Platform Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | AI Demand and ESG Mandates Propel Market to USD 2.95 Billion9:17:39 AM ETSOLV$89.50+0.15(+0.17%)UAE Hospital Supplies Market Size and Share Analysis, Industry Trends, and Growth Forecasts, 2026-2031 | AI Procurement and Infection-Control Demand Fuel 8.10% CAGR9:11:38 AM ETACN$269.80+5.39(+2.04%)Application Outsourcing - Market Size, Share, Industry Trends, and Growth Forecasts, 2026-2031 | Cloud, AI, and Security Demand Drive Market to USD 215.46 Billion9:10:49 AM ETCSCO$100.41-3.25(-3.14%)Desktop Virtualization Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | Cloud DaaS and Hybrid Work Propel Market to USD 20.54 Billion as Asia-Pacific Leads Growth9:09:39 AM ETIBM$252.18-2.14(-0.84%)Industrial Edge Computing Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | Edge AI, IIoT, and Private-5G Drive 13.24% CAGR to USD 114.87 Billion9:08:39 AM ETQUBT$5.85-0.58(-9.02%)Next-generation Computing Market Size, Share, Trends, and Growth Forecasts 2026-2031 | AI, Quantum, and Edge Investment Drive 19.02% CAGR to USD 650.48 Billion9:07:40 AM ETDIS$120.04+1.06(+0.89%)I've Been Writing About Disney Stock for 30 Years. Here's Why My Conviction Has Never Been Higher.9:07:00 AM ET

ANIP · NASDAQ

ANI Pharmaceuticals, Inc.

$74.88 +3.25 (+4.54%)

Company overview

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Market cap
$1.7B
Employees
970
Headquarters
Baudette, MN
Website
anipharmaceuticals.com
CEO
Nikhil Lalwani
Listed
May 5, 2000
P/E
18.23
Dividend yield
0.00%

Company financials

Revenue
$924M
Gross profit
$609M
Operating income
$124M
EBITDA
$237M
Net income
$89.7M
EPS
$4.11
Total assets
$1.4B
Total debt
$328M
Gross margin
65.94%
Net margin
9.71%
Earnings yield
5.49%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

68.8573.7678.6783.5888.49
ANIP 1D NASDAQ O73.22H74.00L71.36C71.63-0.65 (-0.90%)Vol202.22K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
ANIPANI Pharmaceuticals, Inc. Press release ANI Pharmaceuticals Announces Offer to Acquire Egetis Therapeutics, Expanding the Scope and Scale of Its Rare Disease Business GlobeNewswire
ANIPANI Pharmaceuticals, Inc. Stock news BRIEF-Egetis Recommends Public Cash Offer From ANI Pharmaceuticals Reuters
ANIPANI Pharmaceuticals, Inc. Press release ANI Pharmaceuticals to Present at Upcoming November Investor Conferences GlobeNewswire
ANIPANI Pharmaceuticals, Inc. Press release ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ET GlobeNewswire
ANIPANI Pharmaceuticals, Inc. Press release ANI Pharmaceuticals Announces the Launch of Duloxetine Delayed-Release Capsules GlobeNewswire
ANIPANI Pharmaceuticals, Inc. Stock news ANI Pharmaceuticals (NASDAQ:ANIP) CEO Sells $388,206.00 in Stock Defense World
ANIPANI Pharmaceuticals, Inc. Stock news Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report? Zacks Investment Research
ANIPANI Pharmaceuticals, Inc. Stock news These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar Zacks Investment Research
ANIPANI Pharmaceuticals, Inc. Press release ANI Pharmaceuticals Announces Positive Phase 4 Open-Label, Single-Arm SYNCHRONICITY Clinical Trial Results Presented as Late Breaking Oral Presentation at the American Academy of Ophthalmology 2026 Annual Meeting GlobeNewswire
ANIPANI Pharmaceuticals, Inc. Press release ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting GlobeNewswire
ANIPANI Pharmaceuticals, Inc. Stock news Implied Volatility Surging for ANI Pharmaceuticals Stock Options Zacks Investment Research
ANIPANI Pharmaceuticals, Inc. Stock news ANI Pharmaceuticals: Cortrophin's Q4 Test, With Generics Funding The Build Seeking Alpha
ANIPANI Pharmaceuticals, Inc. Press release ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension GlobeNewswire
ANIPANI Pharmaceuticals, Inc. Stock news ANI Pharmaceuticals, Inc. (ANIP) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Seeking Alpha
ANIPANI Pharmaceuticals, Inc. Stock news Contrasting ANI Pharmaceuticals (NASDAQ:ANIP) and Cumberland Pharmaceuticals (NASDAQ:CPIX) Defense World
ANIPANI Pharmaceuticals, Inc. Press release ANI Pharmaceuticals to Present at September Investor Conferences GlobeNewswire
ANIPANI Pharmaceuticals, Inc. Press release ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors GlobeNewswire
ANIPANI Pharmaceuticals, Inc. Stock news Aurora Investment Counsel Takes Position in ANI Pharmaceuticals, Inc. $ANIP Defense World
ANIPANI Pharmaceuticals, Inc. Stock news ANIP's Cortrophin Guidance Cut Raises the Bar for Second-Half Growth Zacks Investment Research
ANIPANI Pharmaceuticals, Inc. Stock news Should You Buy ANIP as Low Valuation Meets Cortrophin Execution Risk? Zacks Investment Research
See more
FAQ

Questions about ANI Pharmaceuticals, Inc.

What does ANI Pharmaceuticals, Inc. do?
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.
What is ANIP's market cap?
ANI Pharmaceuticals, Inc. (ANIP) is a listed stock with a live quote. The latest market cap on this page is $1.7B.
Where is ANI Pharmaceuticals, Inc. headquartered?
ANI Pharmaceuticals, Inc. is headquartered in Baudette, MN.
How do I get ANIP news from the API?
Call GET /v1/news?tickers=ANIP. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does ANIP news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for ANIP, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the ANIP price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs